Lemonaid Health vs MEDVi: Which GLP-1 Provider Is Better?
Short answer: Lemonaid Health scores higher on our rubric, 7.2/10 against 5.7/10. Full reasoning, pricing and the cases where the other one wins are below.
Lemonaid Health beats MEDVi overall, scoring 7.2/10 vs 5.7/10. Published pricing is not a like-for-like monthly comparison: Lemonaid Health is published $129/mo; total not verified; MEDVi is $179 first month, then $299/mo. Choose Lemonaid Health for users who want a flexible membership with broad medication options, $49/mo platform fee + compounded ($199), microdose ($199), or brand-name zepbound via lillydirect ($299-449). Choose MEDVi for users who want both oral and injectable compounded options in one telehealth program.
A side-by-side look at Lemonaid Health and MEDVi to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Lemonaid Health
#37 of 54Established telehealth platform (acquired by 23andMe) restructured in 2026: $49/mo Weight Loss Membership + medication billed separately. Menu now includes compounded sema and tirz, compounded microdoses ($199), and brand-name Zepbound via LillyDirect ($299-449).
Visit Lemonaid HealthMEDVi
#46 of 54MEDVi offers oral and injectable compounded GLP-1 care. Semaglutide is $179 for month one and $299 for refills. Trustpilot is 4.4/5 across roughly 11,000 reviews, while BBB is F/not accredited. FDA warning letter #721455 concerns misleading labeling and marketing, not an allegation that the medication was unsafe.
Visit MEDVi| Feature | Lemonaid Health | MEDVi |
|---|---|---|
| Why each one | One of the oldest and most established telehealth brands in the GLP-1 space, over a decade of operation and physician-only prescribing standards that exceed most competitors. | Oral and injectable compounded formats in one program, with micro-dosing options and a path to FDA-approved brand medication. |
| Our Score | 7.2/10 | 5.7/10 |
| Headline Price | published $129/mo; total not verified | $179 first month, then $299/mo |
| Medication Type | Both | Both |
| Insurance Accepted | No | No |
| Best For | Users who want a flexible membership with broad medication options, $49/mo platform fee + compounded ($199), microdose ($199), or brand-name Zepbound via LillyDirect ($299-449) | Users who want both oral and injectable compounded options in one telehealth program |
| Watch out for | Membership and medication billed separately, the $49/mo number is just the membership, not all-in | FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication |
| Ranking | #37 | #46 |
| Get started | Visit Lemonaid Health | Visit MEDVi |
Pros & Cons Compared
Lemonaid Health
Pros
- +2026 restructure, $49/mo Weight Loss Membership (replaces the old $25/visit model)
- +6-month plan discount, compounded tirzepatide drops to $229/mo on a 6-month commitment
- +Wide medication menu: compounded sema, compounded tirz, compounded microdoses ($199), brand-name Zepbound via LillyDirect ($299-449), and metformin
- +Established since 2013 with physician-only prescribing and rigorous intake
Cons
- −Membership and medication billed separately, the $49/mo number is just the membership, not all-in
- −Brand-name Wegovy ($1,599) and Ozempic ($1,199) cash prices are high, read as access, not value
- −Best compounded pricing requires a 6-month commitment
- −The 23andMe acquisition created some uncertainty about the platform's long-term focus
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +Micro-dosing options available, can start at sub-standard doses for patients concerned about side effects
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179 covers the first month of compounded semaglutide on the current Katalys landing, including clinician review, medication and shipping
Cons
- −FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication
- −Its third-party records conflict: 4.4/5 across roughly 11,000 Trustpilot reviews, but an F and no accreditation at the BBB
- −The $179 semaglutide price is introductory; the current Katalys landing says refills are $299/mo, making the first-year total $3,468 rather than $2,148
- −Brand-name Wegovy and Zepbound paths add a $99 membership plus the medication cost, which the current landing does not publish; availability can change
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms
Our Verdict
Lemonaid Health edges out MEDVi with a score of 7.2/10 vs 5.7/10. Published pricing is not a like-for-like monthly comparison: Lemonaid Health is published $129/mo; total not verified; MEDVi is $179 first month, then $299/mo.
Read Full Reviews
Related comparisons
More head-to-head comparisons involving Lemonaid Health and MEDVi.
Not comparing, just asking? Quick answers to the most-asked GLP-1 questions →
- Lemonaid Health vs Strut Healthfrom $99/mo
- Lemonaid Health vs DudeMedsfrom $149/mo
- Lemonaid Health vs Yucca Healthfrom $146/mo
- MEDVi vs Wellorithmfrom $147/mo
- MEDVi vs SkinnyRxfrom $199/mo
- MEDVi vs Bodybuilding Health+from $179/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Our pick of these two: Lemonaid Health · 7.2/10